Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Intrum in connection with several financing transactions (1)
Mandate

Vinge advises Intrum in connection with several financing transactions

September 20, 2019 Banking and Finance

Vinge has advised Intrum AB (publ) in connection with several financing transactions during the third quarter of 2019.

Intrum issued notes in the amount of 750 MEUR in July  and 850 MEUR in September and entered into a 2,000 MSEK backup credit facility agreement with Nordic banks in July 2019. Vinge has advised Intrum as to matters of Swedish law in relation to all transactions. 

Vinge’s team consisted of amongst others Louise Brorsson Salomon, Josefine Larsson, Pauline Lagerstrand, Jolinn Uhlin and Anders Sundin Lundberg.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026